Medicare Enrolled

Dr. Brian Bruel, M.D., M.B.A

Interventional Pain Medicine Physician · Houston, TX
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Consulting-driven
9717 JONES RD STE 100, Houston, TX 77065
7135686095
In practice since 2007 (18 years)
NPI: 1659563047 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Bruel from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Bruel? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Bruel

Dr. Brian Bruel is an interventional pain medicine physician in Houston, TX, with 18 years in practice. Based on federal Medicare data, Dr. Bruel performed 3,426 Medicare services across 852 unique beneficiaries.

Between the years covered by Open Payments, Dr. Bruel received a total of $233,685 from 74 pharmaceutical and/or device companies across 1125 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in interventional pain medicine physician. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Bruel is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 18 years in practice▲ Top 31% volume in TX$ $233,685 industry payments

Medicare Practice Summary

Medicare Utilization ↗
3,426
Medicare services
Top 31% in TX for interventional pain medicine physician
852
Unique beneficiaries
$52
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~190 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Office visit, established patient (30-39 min)1,086$94$334
Injection, midazolam hydrochloride, per 1 mg540$0$10
Drug screening test483$60$343
Contrast dye for imaging (iodine-based)301$0$10
Office visit, established patient (20-29 min)187$65$236
Injection, methylprednisolone acetate, 40 mg147$6$50
Drug injection, under skin or into muscle127$10$37
Injection, ketorolac tromethamine, per 15 mg108$0$50
Ultrasonic guidance for needle placement77$43$153
Electronic analysis reprogramming and refill of spinal canal drug infusion pump by physician57$68$247
Contrast dye for imaging, lower concentration47$0$10
Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance43$145$431
Steroid injection (triamcinolone)43$1$12
New patient office visit (45-59 min)39$125$434
Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level33$230$661
Electronic analysis of spinal canal drug infusion pump32$23$83
Joint injection, major joint20$52$170
Office visit, established patient, complex (40-54 min)20$137$469
Fluoroscopic guidance for needle placement19$82$310
Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level17$97$299
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
2.6% high complexity
41.6% medium
55.8% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$233,685
Total received (2018-2024)
Avg $33,384/year across 7 years
Top 1% in TX for interventional pain medicine physician
74
Companies
1,125
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$106,258 (45.5%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$91,268 (39.1%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$36,160 (15.5%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$75,850
2023
$29,728
2022
$19,479
2021
$40,645
2020
$19,908
2019
$10,657
2018
$37,419

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Saluda Medical Americas, Inc.
$67,891
BOSTON SCIENTIFIC CORPORATION
$33,796
TerSera Therapeutics LLC
$28,945
Jazz Pharmaceuticals Inc.
$23,733
Medtronic USA, Inc.
$11,657
Biogen, Inc.
$10,727
Boston Scientific Corporation
$9,170
Flowonix Medical Incorporated
$7,655
Medtronic, Inc.
$6,861
Abbott Laboratories
$4,906
MML US, Inc.
$4,129
Relievant Medsystems, Inc.
$3,735
Spinal Simplicity, LLC
$2,776
BIOTRONIK NRO, Inc.
$2,400
Nevro Corp.
$1,894
Nalu Medical, Inc.
$1,193
ABBVIE INC.
$1,155
Daiichi Sankyo Inc.
$1,022
SI-BONE, INC.
$1,013
PAINTEQ LLC
$896
Vertiflex, Inc.
$870
AbbVie Inc.
$832
Merz Pharmaceuticals, LLC
$701
VGI Medical, LLC
$527
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$462
Allergan, Inc.
$358
PFIZER INC.
$339
Collegium Pharmaceutical, Inc.
$328
Biohaven Pharmaceuticals, Inc.
$314
Foundation Fusion Solutions, LLC
$266
Piramal Critical Care
$247
MERZ NORTH AMERICA, INC.
$237
Biohaven Pharmaceutical Holding Company Ltd.
$205
Stimwave Technologies Incorporated
$180
Averitas Pharma Inc.
$157
Horizon Therapeutics plc
$142
Amgen Inc.
$126
AcelRx Pharmaceuticals, Inc.
$124
Curonix LLC
$123
Gilead Sciences, Inc.
$122
GRT US Holding, Inc.
$121
Flexion Therapeutics, Inc.
$118
SPR Therapeutics, Inc
$81
Bioventus LLC
$74
ARBOR PHARMACEUTICALS, INC.
$67
Masimo Corporation
$62
Lilly USA, LLC
$59
Vertos Medical, Inc.
$56
Merz North America, Inc.
$55
IBSA Pharma Inc.
$55
Allergan Inc.
$54
Eisai Inc.
$50
Almatica Pharma LLC
$49
RedHill Biopharma Inc.
$46
Pacira Therapeutics, Inc.
$44
SCILEX PHARMACEUTICALS INC.
$43
Azurity Pharmaceuticals, Inc.
$43
BioDelivery Sciences International, Inc.
$39
Innovation Technologies Inc
$39
BIODELIVERY SCIENCES INTERNATIONAL, INC.
$37
PIRAMAL CRITICAL CARE
$35
Zyla Life Sciences, Inc.
$32
DePuy Synthes Sales Inc.
$28
IDORSIA PHARMACEUTICALS US INC
$22
Hikma Pharmaceuticals USA
$21
Electronic Waveform Lab, Inc.
$17
Kowa Pharmaceuticals America, Inc.
$17
Arbor Pharmaceuticals, Inc.
$17
Novartis Pharmaceuticals Corporation
$16
Stratus Medical, LLC
$16
ASSERTIO THERAPEUTICS, Inc.
$16
HydroCision, Inc.
$14
Scilex Pharmaceuticals Inc.
$14
Currax Pharmaceuticals LLC
$14
Top 3 companies account for 55.9% of total payments
Associated products mentioned in payments ›
AIMOVIG · Accurian · Aimovig · Axium INS DRG IPG · BELBUCA · BOTOX · BOTOX THERAPEUTIC · COMIRNATY · CONTRAVE · Cambia · DRG IPGs · DSUVIA · DUEXIS · Dayvigo · EMGALITY · ETERNA · Evoke · Evoke SCS · GABLOFEN · GABLOFEN 1 mL in 1 SYRINGE · GELSYN 3 · GELSYN-3 · GENERAL THERAPIES · GENERAL PAIN MANAGEMENT · GLASS · GRALISE · General - Pain Management · General - Therapies · HA MINUTEMAN G3-R · HORIZANT · Horizant · IFUSE IMPLANT · IFUSE IMPLANT SYSTEM · INTELLIS · INTELLIS ADAPTIVESTIM · IRRISEPT · Intracept · KYPHON Balloon Kyphoplasty · Kloxxado · LICART · LIORESAL · Movantik · NA · NAPRELAN · NURTEC ODT · Nalu Neurostimulation System · Neuromodulation Dspsbls and Accs · Nimbus · Nucynta · OCTRODE · ORTHOVISC · OSTEOCOOL RF ABLATION · Octrode SCS Leads · Omnia · PAINTEQ · PAXLOVID · PENNSAID · PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A · PRIALT · PROCLAIM · Patient SafetyNet System · PlasmaBlade · Prialt · Proclaim Family of SCS IPGs · Proclaim IPG · Prodigy Family of SCS IPGs · Prometra II · Prospera · QULIPTA · QUTENZA · QUVIVIQ · Qutenza · RELISTOR · ReActiv8 · SCS IPGs · SPECTRA WAVEWRITER · SPINRAZA · SPRINT PNS System · SPRIX · SUPERION · SYNCHROMED · SYNCHROMEDII · Seglentis · Senza · Senza II · Senza Spinal Cord Stimulation System · SiJoin · SiJoin/VerteLoc · Stimrouter Implantable Kit · Superion · Superion ISS · Superion Indirect Decompression System · TENJET · Trodelvy · UBRELVY · V-LOC 180 · VECTRIS · Vanta · WAVEWRITER ALPHA · WaveWriter Alpha Prime 16 · XEOMIN · XTAMPZA · Xeomin · ZTLido · Zilretta · mild Device Kit · movantik
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (46%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers. Total industry engagement is in the top 1% for interventional pain medicine physician in TX.

Equivalent to $6,821 per 100 Medicare services performed
Looking for a interventional pain medicine physician in Houston?
Compare interventional pain medicine physicians in the Houston area by procedure volume, costs, and industry payment transparency.
Browse interventional pain medicine physicians nearby

Geographic Context

Interventional Pain Medicine Physicians within 10 mi
31
Per 100K population
0.7
County median income
$73,104
Nearest hospital
HOUSTON METHODIST WILLOWBROOK HOSPITAL
4.1 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Bruel is a clinical cardiology specialist, with moderate Medicare volume, and high industry engagement (consulting-driven, top 1%), with 18 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Bruel experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Bruel performed 1,086 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Bruel receive payments from pharmaceutical companies?
Yes. Dr. Bruel received a total of $233,685 from 74 companies across 1,125 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Bruel's costs compare to other interventional pain medicine physicians in Houston?
Dr. Bruel's average Medicare payment per service is $52. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Bruel) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →